% | $
Quotes you view appear here for quick access.

Affymax, Inc. Message Board

  • byvoetpp byvoetpp Dec 19, 2012 11:40 AM Flag

    from ws cheat sheet on yahoo finance

    Affymax, Inc. (NASDAQ:AFFY): Piper Jaffray has stated that the U.S. Government Accountability Office, or GAO, published a report on December 7 that recommented that Congress require the Department of Health and Human Services to rebase the End Stage Renal Disease, or ESRD, bundle as Erythropoiesis-Stimulating Agent utilization saw a 23 percent decline from 2007 to 2011, which is the year on which the bundle is based. Piper continues to think that a reduction in the bundle has grown more probable and that dialysis providers will probably require more discounts from drug manufacturers. The firm is convinced that this could potentially cause volatility in shares of Affymax, and it recommends purchasing the stock on weakness.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.061-0.0088(-12.54%)Aug 26 10:53 AMEDT